| male meiosis | GO:0007140 | 37 | 0.256 | |
| organelle fission | GO:0048285 | 170 | 0.227 | |
| dna metabolic process | GO:0006259 | 303 | 0.155 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.145 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.135 | |
| response to cell cycle checkpoint signaling | GO:0072396 | 1 | 0.131 | |
| dna repair | GO:0006281 | 107 | 0.115 | |
| nuclear division | GO:0000280 | 158 | 0.108 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.102 | |
| microtubule nucleation | GO:0007020 | 2 | 0.091 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.071 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.064 | |
| microtubule polymerization or depolymerization | GO:0031109 | 26 | 0.060 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.059 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.056 | |
| microtubule cytoskeleton organization involved in mitosis | GO:1902850 | 4 | 0.050 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.049 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.049 | |
| organelle assembly | GO:0070925 | 177 | 0.045 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.039 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.037 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.036 | |
| metaphase plate congression | GO:0051310 | 2 | 0.036 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.036 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.036 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.036 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.035 | |
| establishment of meiotic spindle orientation | GO:0051296 | 1 | 0.034 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.034 | |
| microtubule based process | GO:0007017 | 236 | 0.033 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.032 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.030 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.028 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.028 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.028 | |
| cleavage furrow formation | GO:0036089 | 2 | 0.027 | |
| dna packaging | GO:0006323 | 30 | 0.026 | |
| mitotic sister chromatid cohesion | GO:0007064 | 1 | 0.026 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.026 | |
| mitotic chromosome condensation | GO:0007076 | 1 | 0.026 | |
| amine metabolic process | GO:0009308 | 45 | 0.025 | |
| microtubule polymerization | GO:0046785 | 12 | 0.025 | |
| oxidation reduction process | GO:0055114 | 342 | 0.025 | |
| organelle localization | GO:0051640 | 179 | 0.025 | |
| protein polymerization | GO:0051258 | 57 | 0.025 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.024 | |
| chromatin organization | GO:0006325 | 206 | 0.024 | |
| germ cell development | GO:0007281 | 185 | 0.024 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.024 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.023 | |
| gland development | GO:0048732 | 330 | 0.023 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.022 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.022 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.022 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.022 | |
| positive regulation of mitotic metaphase anaphase transition | GO:0045842 | 2 | 0.022 | |
| spindle assembly involved in female meiosis | GO:0007056 | 3 | 0.022 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.021 | |
| meiotic spindle organization | GO:0000212 | 9 | 0.021 | |
| spindle assembly involved in meiosis | GO:0090306 | 4 | 0.021 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.021 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.021 | |
| chromosome segregation | GO:0007059 | 48 | 0.021 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.021 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.020 | |
| cell division | GO:0051301 | 120 | 0.020 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.020 | |
| endocytosis | GO:0006897 | 168 | 0.020 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.020 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.020 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.020 | |
| maintenance of location | GO:0051235 | 89 | 0.020 | |
| rhythmic process | GO:0048511 | 174 | 0.019 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.019 | |
| cellular homeostasis | GO:0019725 | 240 | 0.019 | |
| response to radiation | GO:0009314 | 165 | 0.019 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.019 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.018 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.018 | |
| oogenesis | GO:0048477 | 56 | 0.018 | |
| mapk cascade | GO:0000165 | 281 | 0.018 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.018 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.018 | |
| spermatogenesis | GO:0007283 | 284 | 0.018 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.018 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.018 | |
| endomembrane system organization | GO:0010256 | 147 | 0.017 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.017 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.017 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.017 | |
| dna recombination | GO:0006310 | 92 | 0.017 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.017 | |
| cation transport | GO:0006812 | 399 | 0.017 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.017 | |
| male gamete generation | GO:0048232 | 285 | 0.017 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.016 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.016 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.016 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.016 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.016 | |
| t cell activation | GO:0042110 | 289 | 0.016 | |
| meiotic dna repair synthesis | GO:0000711 | 4 | 0.016 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.016 | |
| reciprocal meiotic recombination | GO:0007131 | 16 | 0.016 | |
| muscle tissue development | GO:0060537 | 308 | 0.016 | |
| regulation of mitotic spindle organization | GO:0060236 | 2 | 0.016 | |
| cellularization | GO:0007349 | 1 | 0.016 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.016 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.016 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.016 | |
| membrane organization | GO:0061024 | 245 | 0.016 | |
| protein catabolic process | GO:0030163 | 221 | 0.016 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.016 | |
| forebrain development | GO:0030900 | 302 | 0.016 | |
| cytokine production | GO:0001816 | 319 | 0.015 | |
| spindle assembly involved in mitosis | GO:0090307 | 4 | 0.015 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.015 | |
| protein complex disassembly | GO:0043241 | 40 | 0.015 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.015 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.015 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.015 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.015 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.015 | |
| lateral inhibition | GO:0046331 | 1 | 0.015 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.015 | |
| chromatin modification | GO:0016568 | 187 | 0.015 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.015 | |
| gonad development | GO:0008406 | 141 | 0.014 | |
| male sex differentiation | GO:0046661 | 109 | 0.014 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.014 | |
| spindle assembly | GO:0051225 | 13 | 0.014 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.014 | |
| transmembrane transport | GO:0055085 | 412 | 0.014 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.014 | |
| negative regulation of microtubule polymerization or depolymerization | GO:0031111 | 15 | 0.014 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.014 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.014 | |
| immune effector process | GO:0002252 | 321 | 0.014 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.014 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.014 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.013 | |
| double strand break repair | GO:0006302 | 48 | 0.013 | |
| circulatory system process | GO:0003013 | 197 | 0.013 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.013 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.013 | |
| cell fate commitment | GO:0045165 | 210 | 0.013 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.013 | |
| inflammatory response | GO:0006954 | 244 | 0.013 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.013 | |
| dna biosynthetic process | GO:0071897 | 22 | 0.013 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.013 | |
| cell adhesion | GO:0007155 | 329 | 0.013 | |
| regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0000083 | 3 | 0.013 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.013 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.013 | |
| dephosphorylation | GO:0016311 | 129 | 0.013 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.013 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.012 | |
| ossification | GO:0001503 | 216 | 0.012 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.012 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.012 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.012 | |
| regulation of protein localization | GO:0032880 | 231 | 0.012 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.012 | |
| rna processing | GO:0006396 | 105 | 0.012 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.012 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.012 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.012 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.012 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.012 | |
| mrna metabolic process | GO:0016071 | 84 | 0.012 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.012 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.012 | |
| digestive tract development | GO:0048565 | 190 | 0.012 | |
| meiosis i | GO:0007127 | 60 | 0.012 | |
| female gamete generation | GO:0007292 | 74 | 0.012 | |
| signal transduction involved in cell cycle checkpoint | GO:0072395 | 3 | 0.012 | |
| extracellular structure organization | GO:0043062 | 148 | 0.012 | |
| blood circulation | GO:0008015 | 195 | 0.012 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.012 | |
| notch signaling pathway | GO:0007219 | 71 | 0.012 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.012 | |
| male gonad development | GO:0008584 | 88 | 0.012 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.011 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.011 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.011 | |
| response to corticosterone | GO:0051412 | 1 | 0.011 | |
| astral microtubule organization | GO:0030953 | 3 | 0.011 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.011 | |
| developmental maturation | GO:0021700 | 193 | 0.011 | |
| microtubule depolymerization | GO:0007019 | 15 | 0.011 | |
| protein processing | GO:0016485 | 163 | 0.011 | |
| regulation of spindle organization | GO:0090224 | 2 | 0.011 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.011 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.011 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.011 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.011 | |
| macromolecular complex disassembly | GO:0032984 | 43 | 0.011 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.011 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.011 | |
| locomotory behavior | GO:0007626 | 195 | 0.011 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.011 | |
| dna endoreduplication | GO:0042023 | 4 | 0.011 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.011 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.011 | |
| regulation of microtubule cytoskeleton organization | GO:0070507 | 37 | 0.011 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.011 | |
| stem cell proliferation | GO:0072089 | 117 | 0.011 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.011 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.011 | |
| b cell activation | GO:0042113 | 161 | 0.011 | |
| camera type eye development | GO:0043010 | 266 | 0.011 | |
| skeletal system development | GO:0001501 | 356 | 0.010 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.010 | |
| protein ubiquitination | GO:0016567 | 171 | 0.010 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.010 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.010 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.010 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.010 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.010 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.010 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.010 | |
| cellular protein complex disassembly | GO:0043624 | 36 | 0.010 | |
| protein depolymerization | GO:0051261 | 34 | 0.010 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.010 | |
| pallium development | GO:0021543 | 120 | 0.010 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.010 | |
| leukocyte migration | GO:0050900 | 124 | 0.010 | |
